Results 171 to 180 of about 172,507 (213)

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India. [PDF]

J Family Med Prim Care
Sinha S, Yasmin S, Patra M, Sinha N, Ahmed A.   +4 more
europepmc   +1 more source

The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study. [PDF]

Sci Rep
Hong SH, Hwang SY, Yu JH, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi KM.   +9 more
europepmc   +1 more source

Causal associations of single anthropometric measures and body shape with nonalcoholic fatty liver disease: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Zhai C, Ding X, Huang A, Ge Y, Yang F, Ding Y.   +5 more
europepmc   +1 more source

Associations among serum levels of MMP-1, MMP-2, and METAVIR fibrosis score in patients with nonalcoholic fatty liver disease. [PDF]

Gastroenterol Hepatol Bed Bench
Odkhuu E, Amgalan K, Galsan U, Namkhai UO, Dorjgotov B, Battulga A, Tserendorj BE, Renchindorj A, Ochirchuulgan B, Unurbat E, Bayanzul S.   +10 more
europepmc   +1 more source

Identification of a Risk-Prediction Model for Hypertension Patients Concomitant with Nonalcoholic Fatty Liver Disease. [PDF]

Healthcare (Basel)
Mai X, Li M, Jin X, Huang S, Xu M, Yan B, Wei Y, Long X, Wu Y, Mo Z.   +9 more
europepmc   +1 more source

Sex-Stratified Prediction Models for 5-Year Nonalcoholic Fatty Liver Disease Risk in Thyroid Cancer Patients: A Nationwide Cohort Study. [PDF]

Biomedicines
Cho YB, Park KS.
europepmc   +1 more source

Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Pharmaceuticals (Basel)
Hasanatuludhhiyah N, Mustika A, Kalanjati VP, Miftahussurur M, Uemura N.   +4 more
europepmc   +1 more source

Disrupted host-microbiota crosstalk promotes nonalcoholic fatty liver disease progression by impaired mitophagy. [PDF]

Microbiol Spectr
Yin W, Gao W, Yang Y, Lin W, Chen W, Zhu X, Zhu R, Zhu L, Jiao N.   +8 more
europepmc   +1 more source

Exercise ameliorates nonalcoholic fatty liver disease by reducing the IGFBP5 to IGF1 ratio to activate AMPK pathway. [PDF]

Sci Rep
Yu Y, Zhu G, Zhang Z, Wang H, Zeng L, Xia J, Liu X, Fang C, Liu S, Yang Y, Yu L.   +10 more
europepmc   +1 more source